Javascript must be enabled to continue!
Results of cataract surgery in children with retinoblastoma
View through CrossRef
Purpose. To present results of cataract surgery in children with retinoblastoma. Material and methods. Within the period from 2012 to 2020, cataract surgery was performed in 21 children (22 eyes) with retinoblastoma aged 28 to 155 months (average – 65 months). Tumors of group B occurred in 2 cases, group C – in 4, group D – in 14, group E – in 1. In 8 cases, cataract occurred in a single eye. Posterior capsular cataract was observed in 18 patients, total – in 3. In all cases, the presence of cataract impeded the control of the tumor. Before cataract surgery all children underwent systemic chemotherapy, some of them also underwent intra-arterial and/or intravitreal chemotherapy, external beam radiotherapy, Gamma Knife stereotactic radiosurgery and local treatment modalities (episcleral plaque brachytherapy, thermotherapy, cryotherapy). There were no signs of tumor progression in all cases at the time of cataract surgery. The mean interval between complete tumor regression and cataract surgery was 23 months (range 6–75 months). Results. Full transparency of optical media was achieved in all eyes after surgery. No intraoperative and postoperative complications occurred. The final visual acuity was improved in 12 eyes, in the rest visual acuity could not be determined due to age. There were no signs of tumor recurrence or metastases in mean follow-up after surgery of 29 months (range 3–60). Conclusion. Our experience of cataract surgery in children with complete regression of retinoblastoma was proved to be a safe and effective way to improve visual functions and achieve transparency of optical media. Key words: retinoblastoma, cataract surgery, ophtalmooncology, functional results
Title: Results of cataract surgery in children with retinoblastoma
Description:
Purpose.
To present results of cataract surgery in children with retinoblastoma.
Material and methods.
Within the period from 2012 to 2020, cataract surgery was performed in 21 children (22 eyes) with retinoblastoma aged 28 to 155 months (average – 65 months).
Tumors of group B occurred in 2 cases, group C – in 4, group D – in 14, group E – in 1.
In 8 cases, cataract occurred in a single eye.
Posterior capsular cataract was observed in 18 patients, total – in 3.
In all cases, the presence of cataract impeded the control of the tumor.
Before cataract surgery all children underwent systemic chemotherapy, some of them also underwent intra-arterial and/or intravitreal chemotherapy, external beam radiotherapy, Gamma Knife stereotactic radiosurgery and local treatment modalities (episcleral plaque brachytherapy, thermotherapy, cryotherapy).
There were no signs of tumor progression in all cases at the time of cataract surgery.
The mean interval between complete tumor regression and cataract surgery was 23 months (range 6–75 months).
Results.
Full transparency of optical media was achieved in all eyes after surgery.
No intraoperative and postoperative complications occurred.
The final visual acuity was improved in 12 eyes, in the rest visual acuity could not be determined due to age.
There were no signs of tumor recurrence or metastases in mean follow-up after surgery of 29 months (range 3–60).
Conclusion.
Our experience of cataract surgery in children with complete regression of retinoblastoma was proved to be a safe and effective way to improve visual functions and achieve transparency of optical media.
Key words: retinoblastoma, cataract surgery, ophtalmooncology, functional results.
Related Results
Phacoemulsification in trabeculectomized eyes
Phacoemulsification in trabeculectomized eyes
Abstract.Purpose: To evaluate retrospectively risk indicators for cataract surgery and the effect of phacoemulsification on intraocular pressure (IOP) control in eyes that have u...
Enhancement of vincristine sensitivity in retinoblastoma through Janus kinase inhibition by ruxolitinib
Enhancement of vincristine sensitivity in retinoblastoma through Janus kinase inhibition by ruxolitinib
Chemotherapy remains the main approach conserving vision during the treatment of retinoblastoma, the most prevalent eye cancer in children. Unfortunately, the development of chemor...
An Eye Opener: Lessons Learnt in Retinoblastoma Awareness and Screening Program
An Eye Opener: Lessons Learnt in Retinoblastoma Awareness and Screening Program
Background: Retinoblastoma is most common intraocular malignancy of infancy. Globally screening is recommended for ‘at risk’ children. Despite knowing this, Indian Cancer Society u...
Risk factors for cataract in retinoblastoma management
Risk factors for cataract in retinoblastoma management
AimsTo investigate the risk factors for cataract following eye-preserving therapies for retinoblastoma.MethodsThis retrospective, single-centre cohort study included patients diagn...
Clinical Profile of Paediatric Cataract and Surgery in a Tertiary Eye Care Centre, Nepal
Clinical Profile of Paediatric Cataract and Surgery in a Tertiary Eye Care Centre, Nepal
Introduction: Paediatric cataract is the opacification of lens and its capsule in children below 14 years of age. The management of paediatric cataract is lens aspiration with or w...
Visual function, spectacle independence, and patients’ satisfaction after cataract surgery- a study in the Central Region of Ghana
Visual function, spectacle independence, and patients’ satisfaction after cataract surgery- a study in the Central Region of Ghana
Background: Reduced visual function is associated with diminished quality of life as well as decreased physical and mental health. Poor visual function related to cataracts is also...
Retinoblastoma
Retinoblastoma
Abstract
Retinoblastoma is the commonest malignant eye tumor of childhood affecting 15 per 100,000 live births. Children predisposed to hereditary retinoblas...
Retinoblastoma
Retinoblastoma
Abstract
Retinoblastoma is a malignant tumour that originates in the developing retina and is usually diagnosed in children under...

